# Drug-Drug Interaction Study of TRK-100STP

> **NCT00719758** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TRK-100STP (BERASUS LA)
- **DRUG:** AST-120 (Kremezin®)

## Key facts

- **NCT ID:** NCT00719758
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2008-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719758, "Drug-Drug Interaction Study of TRK-100STP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00719758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*